Proximal Tibial Open Wedge Osteotomy. A Clinical Prospective, Randomized RSA-trial.
Primary Purpose
Osteoarthritis, Knee
Status
Completed
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)
Sponsored by
About this trial
This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring Osteoarthritis, Knee, Osteotomy, Healing, Roentgen Stereometric Analysis
Eligibility Criteria
Inclusion Criteria: Osteoarthritis of medial compartment of the knee, Ahlbäck gr. 1-2 Candidate for proximal tibial medial open-wedge osteotomy Signed informed consent Exclusion Criteria: Prednisolone treatment. NSAID treatment. BMI > or = 35. Previous surgery in lateral knee compartment. Secondary Arthrosis following fracture(s) of the tibial condyle(s). Lack of informed consent.
Sites / Locations
- Northern Orthopaedic Division, Klinik Farsoe, Aalborg University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Active Comparator
Arm Label
1
2
3
Arm Description
Minced Iliac Crest autograft in osteotomysite
Injectable calcium phosphate cement in osteotomysite
Local autograft in the osteotomysite serves as control
Outcomes
Primary Outcome Measures
Migration in mm measured with RSA (Roentgen Stereometric Analysis)
Secondary Outcome Measures
Hip-Knee-Ankle axis
MR of the knee
Markers of chondral degradation
Markers of bone synthesis and degradation
Clinical scores: KOOS, Lysholm, SF12, Knee Score
Histomorphometric evaluation of bone healing and osseous integration of cement
Full Information
NCT ID
NCT00319280
First Posted
April 27, 2006
Last Updated
March 28, 2014
Sponsor
Northern Orthopaedic Division, Denmark
Collaborators
Company CCBR A/S
1. Study Identification
Unique Protocol Identification Number
NCT00319280
Brief Title
Proximal Tibial Open Wedge Osteotomy. A Clinical Prospective, Randomized RSA-trial.
Official Title
Proximal Tibial Open Wedge Osteotomy. Stability and Healing Evaluated in a Clinical Prospective, Randomized Trial Using RSA.
Study Type
Interventional
2. Study Status
Record Verification Date
March 2014
Overall Recruitment Status
Completed
Study Start Date
December 2004 (undefined)
Primary Completion Date
June 2006 (Actual)
Study Completion Date
December 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Northern Orthopaedic Division, Denmark
Collaborators
Company CCBR A/S
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In the treatment of osteoarthritis of the medial compartment of the knee, Open wedge high tibial osteotomy is a good choice of treatment for the young and active patient.
However it leaves an open gap which has to be filled with a bone substitute and requires stable fixation.
Hitherto the golden standard has been autograft taken from iliac crest but there are donorsite related problems and limited amount available.
Recently injectable and resorbable calciumphosphate-cements have been introduced and used with promising results in fractures of the distal radius, calcaneus and lateral tibial condyle.
These new cements seem to be a good alternative to other bone substitutes providing high initial strength that might promote early mobilisation; it resorbs and promotes osteoconduction securing safe healing.
The aim of the present study is to evaluate whether there is any difference in clinical outcome, correction, stability and healing in open-wedge osteotomies with three different bone substitutes: Autograft from iliac crest and the injectable calciumphosphate-cement Calcibon and as control a group with an empty gap.
Osteosynthesis is performed with the Dynafix® system (EBI) The investigation is performed as a randomised prospective clinical trial including 45 patients with a planned 2 years follow-up period.
Clinical outcome is evaluated with: Hospital of special surgery score, KOOS, SF 12 and Lysholm score.
Routine standing x-rays is performed. Stability is assessed with Roentgen Stereophotogrammetric Analysis (RSA) that provides the opportunity of exact 3-dimensional measuring of eventual loss of correction.
This combined with urine and serum bone-healing markers gives a very precise picture of the healing in the bone-gap.
To asses the cartilage of the knee MRI is performed and biochemical markers fore Collagen type II degradation are measured.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee
Keywords
Osteoarthritis, Knee, Osteotomy, Healing, Roentgen Stereometric Analysis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Minced Iliac Crest autograft in osteotomysite
Arm Title
2
Arm Type
Experimental
Arm Description
Injectable calcium phosphate cement in osteotomysite
Arm Title
3
Arm Type
Active Comparator
Arm Description
Local autograft in the osteotomysite serves as control
Intervention Type
Procedure
Intervention Name(s)
bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)
Intervention Description
Osteotomysite are filled with Calcibon (an injectable calcium phosphate cement) or Minced Iliac Crest Bonegraft og local graft as control
Primary Outcome Measure Information:
Title
Migration in mm measured with RSA (Roentgen Stereometric Analysis)
Time Frame
postoperative, at 3 month, 1 and 2 years
Secondary Outcome Measure Information:
Title
Hip-Knee-Ankle axis
Time Frame
3 month, 1 and 2 years.
Title
MR of the knee
Time Frame
4 weeks preoperative, preoperative, at 1 and 2 years postoperative.
Title
Markers of chondral degradation
Time Frame
preoperative, at 6 weeks, 3 month, 1 and 2 years postoperative
Title
Markers of bone synthesis and degradation
Time Frame
preoperative, at 6 weeks, 3 month, 1 and 2 years postoperative
Title
Clinical scores: KOOS, Lysholm, SF12, Knee Score
Time Frame
Preoperatively, Postoperatively, 6 weeks, 3 months, 1 year and 2 years
Title
Histomorphometric evaluation of bone healing and osseous integration of cement
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Osteoarthritis of medial compartment of the knee, Ahlbäck gr. 1-2
Candidate for proximal tibial medial open-wedge osteotomy
Signed informed consent
Exclusion Criteria:
Prednisolone treatment.
NSAID treatment.
BMI > or = 35.
Previous surgery in lateral knee compartment.
Secondary Arthrosis following fracture(s) of the tibial condyle(s).
Lack of informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Lind-Hansen, MD
Organizational Affiliation
Northern Orthopaedic Division, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Northern Orthopaedic Division, Klinik Farsoe, Aalborg University Hospital
City
Farsoe
State/Province
Northern Jutland
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
Proximal Tibial Open Wedge Osteotomy. A Clinical Prospective, Randomized RSA-trial.
We'll reach out to this number within 24 hrs